Background - A viral cause of idiopathic pulmonary fibrosis (IPF) was
recently suggested by a Japanese study in which a high prevalence of a
nti-hepatitis C virus (HCV) antibodies was detected. A subsequent Brit
ish study failed to confirm these results. Methods - Antibodies to HCV
were evaluated in 60 patients with IPF, 130 patients with non-interst
itial lung disease, and in 4614 blood donors. HCV-RNA and HCV genotype
s were evaluated in the anti-HCV positive patients with IPF. Anti-HCV
antibodies were evaluated by ELISA and confirmed by recombinant immuno
blotting assay (RIBA). HCV-RNA and genotypes were detected by reverse
transcriptase polymerase chain reaction (PCR). Results - Eight patient
s with IPF had anti-HCV antibodies detected by ELISA (13.3%). In the b
lood donor control group the prevalence of HCV antibodies was lower (0
.3%). In patients with non-interstitial lung disease HCV antibody prev
alence was 6.1%. In all eight patients with IPF found to be anti-HCV p
ositive by ELISA, HCV antibodies were also detected by RIBA. Furthermo
re, all were HCV-RNA positive by PCR assay. HCV genotypes were identif
ied in four of these eight patients. In all four genotype II was prese
nt and in two it was associated with genotype III and/or genotype IV.
In the remaining four cases the genotype was not identified. Conclusio
n - Italian patients with IPF show an increased prevalence (similar to
13%) of HCV infection and viral replication, but the prevalence of an
ti-HCV antibodies does not differ from other lung diseases.